We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Patient Portal Now Available As a Cloud Service

By MedImaging International staff writers
Posted on 03 Mar 2013
Print article
A new patient portal encourages patients to securely access, share, and manage their medical images and radiology reports with healthcare providers. It also positions US healthcare providers to meet stage 2 meaningful use (MU) requirements. The portal will be available as a cloud service in March 2013.

Implementing the portal as a Vue Cloud Service, developed by Carestream Health (Rochester, NY, USA), provides the flexibility of a monthly fee, and it can accommodate more users without additional network expansions. Carestream manages remote access, networking requirements and security procedures for users of its cloud services, while also addressing regulatory compliance and service uptime.

MyVue is also available as an on-site portal for users of Carestream’s Vue picture archiving and communication system (PACS) and Vue Archive, a vendor-neutral archiving solution that supports third-party PACS platforms.

The Ferrara Hospital (Ferrara, Italy) conducted an on-site trade trial of the MyVue patient portal as an on-site deployment. The hospital serves a population of more than 350,000 and conducts about 150,000 radiographic scans yearly. “MyVue is very attractive for patients because it enables them to have immediate access to their reports and images from their homes. More than 98% of our patients who participated in the trial were so enthusiastic about the product that they decided to continue using it,” said Giorgio Benea, the hospital’s director of diagnostic imaging. “In addition to providing a more efficient way to deliver imaging data to patients, our hospital gains a favorable reputation for deploying truly innovative technology.”

When patients arrived at admissions, they were offered the option to access imaging exam findings using the new patient portal. Patients that accepted received a password and links to access their own personal web page that contained their exams.

“MyVue helps empower patients to play a greater role in their medical care and gives healthcare providers an important tool in building patient satisfaction and loyalty,” said Cristine Kao, Carestream’s global marketing manager for Healthcare Information Solutions. “And since it’s so convenient for physicians to use, MyVue can help enhance referral volumes.”

Ferrara patients found the MyVue portal easy to use. “The MyVue portal requires no special knowledge of computers or applications, since each section has clear directions to guide users,” Dr. Benea said. By clicking on intuitive icons, patients can share an imaging exam with physicians and can also download the files via the web.

The MyVue portal e-mails a secure login to each patient, and medical images and reports can be accessed through the secure login from a variety of Web-browser enabled devices. No software downloads are required for patients or physicians. MyVue’s HTML5 viewer can be deployed on web-enabled devices such as the iPad and complements Vue Motion, Carestream’s vendor-independent image viewer for clinicians and referring physicians. Both MyVue and Vue Motion can help increase referring physicians’ approval and boosts the exchange of imaging exams.

Related Links:
Carestream Health

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Color Doppler Ultrasound System
DRE Crystal 4PX
Ultrasound Needle Guide
Ultra-Pro II
New
Digital Radiography Generator
meX+20BT lite

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more